The cb-EPS from each probiotic micro organism prevented the proliferation of HT-29 colon most cancers cells. In addi- tion, the cytotoxic and anti-proliferative results of the exopolysaccharide extract from each micro organism in L-929 fibro- blasts had been a lot decrease than HT-29 cells. The induction of apoptosis in HT-29 cells was noticed at 48h in contrast with 72h. Evidently the exopolysaccharides extracted from each micro organism have a higher impact on the induction of apoptosis at 48h. The cb-EPS of L. brevis confirmed stronger anti-proliferative and apoptotic properties than the cb- EPS of L. paracasei. The ladder sample of DNA fragmentation confirmed the induction of apoptosis in most cancers cells.
The outcomes of the MTT assay and apoptosis point out that the induction of apoptosis by the exopolysac- charide from micro organism depends upon the dose, time, and pressure of micro organism. Additional research could contribute towards the understanding of utilizing these probiotic micro organism as organic merchandise to deal with and forestall cancers. The science of studying well being techniques borrows and adapts fashions from many fields.
One specifically is implementation science which has been experiencing a flourishing of recent theories, fashions, and frameworks, a few of that are producing enough proof as to their effectiveness and applicability to emerge as candidates for huge adoption as helpful instruments for the sphere. In reviewing these, a typical paradigm might be described which is a synthesis of these components recurrently cited by well being techniques implementing profitable transformational change actions. As a paradigm, it presents a sensible bridge to those fashions, ideas, and frameworks which can be usually exhausting to operationalize and are used with various levels of completeness.
Fusarium proliferatum, a New Pathogen Inflicting Head Blight on Oat in Argentina.
Oat (Avena sativa L.) is broadly grown (~200,000 ha) for livestock feed in Argentina. Fusarium spp. have an effect on yield and industrial high quality and might trigger oblique losses as a result of some Fusarium spp. produce mycotoxins. In December 2008, a examine of oat seeds (cv. Graciela INTA) from Trenque Lauquen, Buenos Aires, Argentina was performed. Seeds (400) had been floor sterilized by dipping successively into 70% ethanol for two min, 5% sodium hypochlorite for two min, rinsed twice in recent sterilized distilled water, plated on 2% potato dextrose agar (PDA) pH 6, and incubated at 24 ± 2°C with 12-h photoperiods. Six isolates morphologically just like Fusarium spp. had been noticed after 6 days of incubation.
For identification, monosporic isolates had been transferred onto 2% PDA and carnation leaf agar (CLA) to develop with the situations described above. Two isolates produced ample, white, aerial mycelium and violet-to-dark (with age) pigments within the PDA. On CLA, macroconidia had been ample, slender, nearly straight, skinny walled, and normally three to 5 septate. Microconidia had been ample, normally single celled, oval or club-shaped in chains (much less generally in false heads) on monophialides and polyphialides. Chlamydospores had been absent.
The fungus was recognized as Fusarium proliferatum (Matsushima) Nirenberg on the idea of fungal morphology (1). To finish Koch’s postulates, the pathogenicity of the fungus was examined by spraying 5 wholesome inflorescences of oat (cv. Graciela INTA) with a 5-ml suspension (2 × 105 conidia/ml). One other two wholesome inflorescences had been sprayed with sterile distilled water. Vegetation had been positioned in a progress chamber with a 12-h photoperiod at 22 ± 2°C and lined with polyethylene luggage that had been eliminated after Three days and crops had been moved to a glasshouse. This process was repeated.
Nilotinib induction of melanogenesis by way of reactive oxygen species-dependent JNK activation in B16F0 mouse melanoma cells.
Nilotinib (AMN), a second-generation tyrosine kinase inhibitor, induces apoptosis in varied most cancers cells, and our current examine confirmed that AMN successfully decreased the viability of human ovarian most cancers cells by way of mitochondrion-dependent apoptosis. The impact of AMN within the melanogenesis of melanoma cells continues to be unclear. Within the current examine, we discovered that the addition of AMN however not imatinib (STI) considerably elevated the darkness of B16F0 melanoma cells, and the absorptive worth elevated with the focus of AMN.
A lower within the viability of B16F0 cells by AMN was detected in a concentration-dependent method, accompanied by elevated DNA ladders, hypodiploid cells and cleavage of the caspase-Three protein. An in vitro tyrosinase (TYR) exercise assay confirmed that elevated TYR exercise by AMN was detected in a concentration-dependent method; nonetheless, induction of TYR exercise by STI at a focus of 40 μmol/L was noticed. Elevated intracellular peroxide by AMN was detected in B16F0 cells, and utility of the antioxidant, N-acetylcysteine (NAC), considerably decreased AMN-induced peroxide manufacturing which additionally decreased the darkness of B16F0 cells.
Chikungunya virus RT PCR kit |
RTq-H525-150R |
Bioingentech |
150T |
EUR 2144.4 |
Chikungunya virus RT PCR kit |
RTq-H525-50R |
Bioingentech |
50T |
EUR 1155.6 |
CHIKUNGUNYA DETECTION KIT (REAL TIME PRO |
MBPCR112-10R |
EWC Diagnostics |
1 unit |
EUR 115.82 |
Description: CHIKUNGUNYA DETECTION KIT (REAL TIME PRO |
CHIKUNGUNYA DETECTION KIT (REAL TIME PRO |
MBPCR112-50R |
EWC Diagnostics |
1 unit |
EUR 505.92 |
Description: CHIKUNGUNYA DETECTION KIT (REAL TIME PRO |
Chikungunya Vines Real-Time PCR Test |
P0066 |
CTK Biotech |
96 |
EUR 5500 |
|
Chikungunya virus PCR kit |
PCR-H525-48R |
Bioingentech |
50T |
EUR 987.6 |
Chikungunya virus PCR kit |
PCR-H525-96R |
Bioingentech |
100T |
EUR 1335.6 |
genesig Std Real-time PCR detection kit for Chikungunya Vir |
Z-Path-CHIKV-std |
Novacyt Group |
150 tests |
EUR 602 |
|
Description: CHIKV |
Chikungunya virus One-Step PCR kit |
Oneq-H525-100R |
Bioingentech |
100T |
EUR 1932 |
Chikungunya virus One-Step PCR kit |
Oneq-H525-150R |
Bioingentech |
150T |
EUR 2646 |
Chikungunya virus One-Step PCR kit |
Oneq-H525-50R |
Bioingentech |
50T |
EUR 1410 |
ViPrimePLUS Chikungunya Virus RT-qPCR Kit, 150rxns |
QM5004 |
Vivantis |
each |
Ask for price |
Chikungunya virus |
3584 |
Virostat |
100 ug |
EUR 270 |
Description: This is purified Mouse monoclonal antibody against Chikungunya virus for WB, ELISA. |
Chikungunya virus |
Oneq-H525-OneqH525100R |
Bioingentech |
Oneq-H525-100R |
EUR 1028 |
Chikungunya virus |
Oneq-H525-OneqH525150R |
Bioingentech |
Oneq-H525-150R |
EUR 1438 |
Chikungunya virus |
Oneq-H525-OneqH52550R |
Bioingentech |
Oneq-H525-50R |
EUR 728 |
Chikungunya virus |
PCR-H525-PCRH52548R |
Bioingentech |
PCR-H525-48R |
EUR 485 |
Chikungunya virus |
PCR-H525-PCRH52596R |
Bioingentech |
PCR-H525-96R |
EUR 685 |
Chikungunya Virus |
MBS320438-01mg |
MyBiosource |
0.1mg |
EUR 355 |
Chikungunya Virus |
MBS320438-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1500 |
Chikungunya Virus |
MBS320439-01mg |
MyBiosource |
0.1mg |
EUR 355 |
Chikungunya Virus |
MBS320439-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1500 |
Chikungunya Virus |
MBS320440-01mg |
MyBiosource |
0.1mg |
EUR 355 |
Chikungunya Virus |
MBS320440-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1500 |
Chikungunya Virus (CHIKV) |
MBS6507258-01mg |
MyBiosource |
0.1mg |
EUR 580 |
Chikungunya Virus (CHIKV) |
MBS6507258-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2470 |
Chikungunya Virus (CHIKV) |
MBS6507259-01mg |
MyBiosource |
0.1mg |
EUR 580 |
Chikungunya Virus (CHIKV) |
MBS6507259-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2470 |
Chikungunya Virus IgG ELISA Kit |
ESR148G |
Genovis AB |
96 Tests |
EUR 372 |
Chikungunya Virus IgM ELISA Kit |
ESR148M |
Genovis AB |
96 Tests |
EUR 372 |
Chikungunya virus antibody |
10-2716 |
Fitzgerald |
500 ug |
EUR 295 |
|
Description: Mouse monoclonal Chikungunya virus envelope antibody |
Chikungunya virus antibody |
10-2717 |
Fitzgerald |
500 ug |
EUR 295 |
|
Description: Mouse monoclonal Chikungunya virus envelope antibody |
Chikungunya virus antibody |
10-2718 |
Fitzgerald |
500 ug |
EUR 300 |
|
Description: Mouse monoclonal Chikungunya virus envelope antibody |
Chikungunya virus antibody |
10-2719 |
Fitzgerald |
250 ug |
EUR 492 |
|
Description: Mouse monoclonal Chikungunya virus antibody |
Chikungunya virus antibody |
10-2720 |
Fitzgerald |
250 ug |
EUR 590 |
|
Description: Mouse monoclonal Chikungunya virus antibody |
Chikungunya Virus Antibody |
abx021574-1mg |
Abbexa |
1 mg |
EUR 1296 |
|
Chikungunya Virus Antibody |
abx021574-400l |
Abbexa |
400 µl |
Ask for price |
Chikungunya Virus Antibody |
abx021574-80l |
Abbexa |
80 µl |
EUR 1250 |
Chikungunya Virus Antibody |
abx021575-1mg |
Abbexa |
1 mg |
EUR 1296 |
|
Chikungunya Virus Antibody |
abx021575-400l |
Abbexa |
400 µl |
Ask for price |
Chikungunya Virus Antibody |
abx021575-80l |
Abbexa |
80 µl |
EUR 1250 |
Chikungunya Virus Antibody |
abx021576-1mg |
Abbexa |
1 mg |
EUR 1296 |
|
Chikungunya Virus Antibody |
abx021576-400l |
Abbexa |
400 µl |
Ask for price |
Chikungunya Virus Antibody |
abx021576-80l |
Abbexa |
80 µl |
EUR 1250 |
MAb to Chikungunya Virus |
MBS313119-1mg |
MyBiosource |
1mg |
EUR 1000 |
MAb to Chikungunya Virus |
MBS313119-5x1mg |
MyBiosource |
5x1mg |
EUR 4330 |
MAb to Chikungunya Virus |
MBS313129-1mg |
MyBiosource |
1mg |
EUR 1000 |
MAb to Chikungunya Virus |
MBS313129-5x1mg |
MyBiosource |
5x1mg |
EUR 4330 |
MAb to Chikungunya Virus |
MBS313140-1mg |
MyBiosource |
1mg |
EUR 1000 |
MAb to Chikungunya Virus |
MBS313140-5x1mg |
MyBiosource |
5x1mg |
EUR 4330 |
Chikungunya virus E1 protein |
30-1942 |
Fitzgerald |
100 ug |
EUR 1500 |
|
Description: Recombinant Chikungunya virus E1 protein - wild type |
Chikungunya Virus IgG capture |
GWB-C324EF |
GenWay Biotech |
1x96 Assays |
Ask for price |
Chikungunya virus envelope E1 |
MBS596103-1mg |
MyBiosource |
1mg |
EUR 425 |
Chikungunya virus envelope E1 |
MBS596103-2mg |
MyBiosource |
2mg |
EUR 700 |
Chikungunya virus envelope E1 |
MBS596103-5mg |
MyBiosource |
5mg |
EUR 1505 |
Chikungunya virus envelope E2 |
MBS596329-1mg |
MyBiosource |
1mg |
EUR 425 |
Chikungunya virus envelope E2 |
MBS596329-2mg |
MyBiosource |
2mg |
EUR 700 |
Chikungunya virus envelope E2 |
MBS596329-5mg |
MyBiosource |
5mg |
EUR 1505 |
Human chikungunya virus,CHIKV ELISA KIT |
JOT-EKD0218Hu |
Jotbody |
96 wells |
EUR 366.4 |
Description: Human |
Human chikungunya virus, CHIKV ELISA Kit |
MBS1610573-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3460 |
Human chikungunya virus, CHIKV ELISA Kit |
MBS1610573-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1750 |
Human chikungunya virus, CHIKV ELISA Kit |
MBS1610573-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 425 |
Human Chikungunya Virus (CHIKV) ELISA Kit |
SL3467Hu |
Sunlong |
96 Tests |
EUR 468 |
|
Chikungunya virus gpE2 protein |
30-1939 |
Fitzgerald |
100 ug |
EUR 1560 |
|
Description: Recombinant Chikungunya virus Glycoprotein E2 protein - wild type |
Chikungunya virus gpE1 protein |
30-1940 |
Fitzgerald |
100 ug |
EUR 1560 |
|
Description: Recombinant Chikungunya virus Glycoprotein E1 protein - wild type |
Chikungunya virus gpE1 protein |
30-1944 |
Fitzgerald |
100 ug |
EUR 1184 |
|
Description: Recombinant Chikungunya virus Glycoprotein E1 protein - wild type |
genesig Easy kit for Chikungunya Virus |
Z-Path-CHIKV-EASY |
Novacyt Group |
50 tests |
EUR 410 |
Description: CHIKV |
Eukaryotic Chikungunya Virus (CHIKV) |
EPX256Ge41 |
Cloud-Clone |
10ug |
EUR 240 |
Eukaryotic Chikungunya Virus (CHIKV) |
MBS2124339-001mg |
MyBiosource |
0.01mg |
EUR 205 |
Eukaryotic Chikungunya Virus (CHIKV) |
MBS2124339-005mg |
MyBiosource |
0.05mg |
EUR 400 |
Eukaryotic Chikungunya Virus (CHIKV) |
MBS2124339-01mg |
MyBiosource |
0.1mg |
EUR 610 |
Eukaryotic Chikungunya Virus (CHIKV) |
MBS2124339-02mg |
MyBiosource |
0.2mg |
EUR 745 |
Eukaryotic Chikungunya Virus (CHIKV) |
MBS2124339-05mg |
MyBiosource |
0.5mg |
EUR 1435 |
recombinant Chikungunya Virus E2 |
E4A10F32-E2 |
EnoGene |
100ug |
EUR 595 |
Recombinant Chikungunya Virus E1 |
P1113-10 |
Biovision |
each |
EUR 614.4 |
Recombinant Chikungunya Virus (CHIKV) |
MBS2105664-001mg |
MyBiosource |
0.01mg |
EUR 195 |
Recombinant Chikungunya Virus (CHIKV) |
MBS2105664-005mg |
MyBiosource |
0.05mg |
EUR 370 |
Recombinant Chikungunya Virus (CHIKV) |
MBS2105664-01mg |
MyBiosource |
0.1mg |
EUR 560 |
Recombinant Chikungunya Virus (CHIKV) |
MBS2105664-02mg |
MyBiosource |
0.2mg |
EUR 685 |
Recombinant Chikungunya Virus (CHIKV) |
MBS2105664-05mg |
MyBiosource |
0.5mg |
EUR 1320 |
Recombinant Chikungunya Virus (CHIKV) |
RPX256Ge01 |
Cloud-Clone |
10ug |
EUR 220 |
Recombinant Chikungunya Virus (CHIKV) |
4-RPX256Ge01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 5 mg
- 10ug
- 50ug
- 100 ug
- 200 ug
- 500 ug
- 1 mg
|
|
Description: Recombinant Pan-species Chikungunya Virus expressed in: E.coli |
Recombinant Chikungunya Virus VLP |
DAGA-3014 |
Creative Diagnostics |
100ug |
EUR 1091.48 |
|
Description: Recombinant |
Chikungunya Virus Envelope Antibody |
abx024072-1mg |
Abbexa |
1 mg |
EUR 1161.6 |
|
Chikungunya Virus Envelope Antibody |
abx024073-1mg |
Abbexa |
1 mg |
EUR 1161.6 |
|
Chikungunya Virus Envelope Antibody |
abx024074-1mg |
Abbexa |
1 mg |
EUR 1161.6 |
|
Chikungunya Virus Envelope Antibody |
abx024074-400l |
Abbexa |
400 µl |
Ask for price |
Chikungunya Virus Envelope Antibody |
abx024074-80l |
Abbexa |
80 µl |
EUR 1037.5 |
Chikungunya Virus Envelope Antibody |
abx024075-1mg |
Abbexa |
1 mg |
EUR 1161.6 |
|
Chikungunya Virus Envelope Antibody |
abx024075-400l |
Abbexa |
400 µl |
Ask for price |
Chikungunya Virus Envelope Antibody |
abx024075-80l |
Abbexa |
80 µl |
EUR 1037.5 |
Chikungunya Virus Envelope Antibody |
abx024076-1mg |
Abbexa |
1 mg |
EUR 1161.6 |
|
Chikungunya Virus Envelope Antibody |
abx024076-400l |
Abbexa |
400 µl |
Ask for price |
Chikungunya Virus Envelope Antibody |
abx024076-80l |
Abbexa |
80 µl |
EUR 1037.5 |
OVA Conjugated Chikungunya Virus (CHIKV) |
CPX256Ge21 |
Cloud-Clone |
10ug |
EUR 220 |
OVA Conjugated Chikungunya Virus (CHIKV) |
4-CPX256Ge21 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 5 mg
- 10ug
- 50ug
- 100 ug
- 200 ug
- 500 ug
- 1 mg
|
|
Description: Recombinant Pan-species Chikungunya Virus expressed in: Protein conjugation |
OVA Conjugated Chikungunya Virus (CHIKV) |
MBS2105202-001mg |
MyBiosource |
0.01mg |
EUR 195 |
OVA Conjugated Chikungunya Virus (CHIKV) |
MBS2105202-005mg |
MyBiosource |
0.05mg |
EUR 370 |
OVA Conjugated Chikungunya Virus (CHIKV) |
MBS2105202-01mg |
MyBiosource |
0.1mg |
EUR 560 |
OVA Conjugated Chikungunya Virus (CHIKV) |
MBS2105202-02mg |
MyBiosource |
0.2mg |
EUR 685 |
OVA Conjugated Chikungunya Virus (CHIKV) |
MBS2105202-05mg |
MyBiosource |
0.5mg |
EUR 1320 |
Mouse Anti Chikungunya Virus VLP (D7) |
MAB12385-100 |
The Native Antigen Company |
0.1 |
EUR 345.07 |
|
Description: Mouse monoclonal antibody specific for Chikungunya virus VLP (clone D7) |
Mouse Anti Chikungunya Virus VLP (D7) |
MAB12385-200 |
The Native Antigen Company |
0.2 |
EUR 494.42 |
|
Description: Mouse monoclonal antibody specific for Chikungunya virus VLP (clone D7) |
Mouse Anti Chikungunya Virus VLP (D7) |
MAB12385-500 |
The Native Antigen Company |
0.5 |
EUR 1467.82 |
|
Description: Mouse monoclonal antibody specific for Chikungunya virus VLP (clone D7) |
Mouse Anti Chikungunya Virus VLP (AG7) |
MAB12313-100 |
The Native Antigen Company |
0.1 |
EUR 279.4 |
|
Description: Mouse monoclonal antibody specific for Chikungunya virus VLP (clone AG7) |
Mouse Anti Chikungunya Virus VLP (AG7) |
MAB12313-500 |
The Native Antigen Company |
0.5 |
EUR 699.15 |
|
Description: Mouse monoclonal antibody specific for Chikungunya virus VLP (clone AG7) |
Mouse Anti Chikungunya Virus VLP (EB6) |
MAB12314-100 |
The Native Antigen Company |
0.1 |
EUR 279.4 |
|
Description: Mouse monoclonal antibody specific for Chikungunya virus VLP (clone EB6) |
Mouse Anti Chikungunya Virus VLP (EB6) |
MAB12314-500 |
The Native Antigen Company |
0.5 |
EUR 699.15 |
|
Description: Mouse monoclonal antibody specific for Chikungunya virus VLP (clone EB6) |
Human Chikungunya Virus IgG,CHIKV IgG ELISA KIT |
JOT-EKD0231Hu |
Jotbody |
96 wells |
EUR 366.4 |
Description: Human |
Human Chikungunya Virus IgG, CHIKV IgG ELISA Kit |
MBS1610578-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3460 |
Human Chikungunya Virus IgG, CHIKV IgG ELISA Kit |
MBS1610578-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1750 |
Human Chikungunya Virus IgG, CHIKV IgG ELISA Kit |
MBS1610578-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 425 |
Human Chikungunya Virus IgG (CHIKV IgG) ELISA Kit |
MBS167847-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3375 |
Human Chikungunya Virus IgG (CHIKV IgG) ELISA Kit |
MBS167847-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 1715 |
Human Chikungunya Virus IgG (CHIKV IgG) ELISA Kit |
MBS167847-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 425 |
Hi-PCR® Chikungunya SYBr PCR Kit |
MBPCR083-10R |
EWC Diagnostics |
1 unit |
EUR 48.94 |
Description: Hi-PCR® Chikungunya SYBr PCR Kit |
Hi-PCR® Chikungunya SYBr PCR Kit |
MBPCR083-50R |
EWC Diagnostics |
1 unit |
EUR 208.63 |
Description: Hi-PCR® Chikungunya SYBr PCR Kit |
Monoclonal Antibody to Chikungunya Virus |
MBS410081-1mg |
MyBiosource |
1mg |
EUR 710 |
Monoclonal Antibody to Chikungunya Virus |
MBS410082-1mg |
MyBiosource |
1mg |
EUR 710 |
Monoclonal Antibody to Chikungunya Virus |
MBS410083-1mg |
MyBiosource |
1mg |
EUR 680 |
Monoclonal antibody to Chikungunya virus |
MBS596233-1mg |
MyBiosource |
1mg |
EUR 480 |
Monoclonal antibody to Chikungunya virus |
MBS596233-2mg |
MyBiosource |
2mg |
EUR 700 |
Monoclonal antibody to Chikungunya virus |
MBS596233-5mg |
MyBiosource |
5mg |
EUR 1505 |
Human Chikungunya Virus IgG (CHIKV-IgG) ELISA Kit |
abx054994-100g |
Abbexa |
100 µg |
Ask for price |
Human Chikungunya Virus IgG (CHIKV-IgG) ELISA Kit |
abx054994-10g |
Abbexa |
10 µg |
EUR 493.75 |
Human Chikungunya Virus IgG (CHIKV-IgG) ELISA Kit |
abx054994-50g |
Abbexa |
50 µg |
Ask for price |
Human Chikungunya Virus IgG (CHIKV-IgG) ELISA Kit |
abx054994-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Human Chikungunya Virus IgM (CHIKV-IgM) ELISA Kit |
abx055296-100g |
Abbexa |
100 µg |
Ask for price |
Human Chikungunya Virus IgM (CHIKV-IgM) ELISA Kit |
abx055296-10g |
Abbexa |
10 µg |
EUR 493.75 |
Human Chikungunya Virus IgM (CHIKV-IgM) ELISA Kit |
abx055296-50g |
Abbexa |
50 µg |
Ask for price |
Human Chikungunya Virus IgM (CHIKV-IgM) ELISA Kit |
abx055296-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Human chikungunya virus IgG (CHIKV-IgG) Elisa Kit |
EK700016 |
AFG Bioscience LLC |
96 Wells |
EUR 0.15 |
Human chikungunya virus IgM(CHIKV-IgM) Elisa Kit |
EK711693 |
AFG Bioscience LLC |
96 Wells |
EUR 0.19 |
Human chikungunya virus IgG (CHIKV-IgG) ELISA Kit |
SL2049Hu |
Sunlong |
96 Tests |
EUR 468 |
|
Human chikungunya virus IgM (CHIKV-IgM) ELISA Kit |
SL2160Hu |
Sunlong |
96 Tests |
EUR 468 |
|
Chikungunya Virus IgM μ-capture ELISA |
GWB-7CF864 |
GenWay Biotech |
1x96 Assays |
Ask for price |
Chikungunya Virus VLP (E1 E2 C protein) |
CHIKV-VLP-100 |
The Native Antigen Company |
0.1 |
EUR 717.17 |
|
Description: Recombinant Chikungunya Virus-Like Particles produced in 293 human cells. Chikungunya structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles are totally non-infectious. |
Chikungunya Virus VLP (E1 E2 C protein) |
CHIKV-VLP-1000 |
The Native Antigen Company |
1.0 |
EUR 4792.31 |
|
Description: Recombinant Chikungunya Virus-Like Particles produced in 293 human cells. Chikungunya structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles are totally non-infectious. This product is prepared from HEK293 cells cultured in fully synthetic media. No animal products are used during the production process. |
Chikungunya Virus VLP (E1 E2 C protein) |
CHIKV-VLP-500 |
The Native Antigen Company |
0.5 |
EUR 2661.39 |
|
Description: Recombinant Chikungunya Virus-Like Particles produced in 293 human cells. Chikungunya structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles are totally non-infectious. This product is prepared from HEK293 cells cultured in fully synthetic media. No animal products are used during the production process. |
Mouse monoclonal Chikungunya virus antibody |
MBS5305728-05mg |
MyBiosource |
0.5mg |
EUR 990 |
Mouse monoclonal Chikungunya virus antibody |
MBS5305728-5x05mg |
MyBiosource |
5x0.5mg |
EUR 4305 |
Moreover, AMN induced c-Jun N-terminal kinase (JNK) protein phosphorylation in B16F0 cells, which was inhibited by the addition of NAC. AMN-induced melanogenesis of B16F0 cells was considerably inhibited by the addition of NAC and the JNK inhibitor, SP600125 (SP). Information of Western blotting confirmed that elevated protein ranges of melanogenesis-related enzymes of tyrosinase-related protein-1 (TRP1), TRP2 and TYR had been noticed in AMN-treated B16F0 cells which had been inhibited by the addition of NAC and SP. Proof is supplied supporting AMN successfully inducing the melanogenesis of B16F0 melanoma cells by way of reactive oxygen species-dependent JNK activation.